GENE ONLINE|News &
Opinion
Blog

Feature
COVID-19 Antibody Cocktail
Brii Bio’s COVID-19 Antibody Cocktail Sees Promising Results in Phase 3 ACTIV-2 Trial
2021-08-26
Delivery System
Scientists Unveil Novel Protein That Delivers Molecular Medicines to Human Cells
2021-08-25
Interviews RNA Editing
Years After Playing Second Fiddle to CRISPR, RNA Editing Comes Into Its Own – An Interview with Dr. Joshua Rosenthal
2021-08-25
Deals RNA Editing
Roche Bets on Shape’s RNA Editing Tech in $3B Gene Therapy Collab
2021-08-25
Birth Control
Could This Anti-Sperm Immunocontraception Work As a Novel Female Birth Control?
2021-08-24
Ranking & Reports RNA Editing
The 6 Companies Leading the Resurgence in RNA Editing R&D
2021-08-24
M&A Immuno-oncology
Pfizer Jumps into the CD47 Race With $2.3B Buyout of Trillium
2021-08-24
RNA Editing
New Era in Precision Medicine? Introduction & Overview of RNA Editing
2021-08-23
Pfizer/BioNTech’s COVID-19 Vaccine Notches Full Approval from USFDA
2021-08-23
Trials & Approvals Glioblastoma
HebaBiz Biotech Obtains FDA Clearance to Trial Cancer Drug Against Aggressive Brain Tumor
2021-08-22
China Series C Funding
China’s Abogen Raises $700M to Fund the First Homegrown mRNA COVID-19 Vaccine to Enter Human Trial
2021-08-20
M&A Federal Trade Commission
Illumina Completes GRAIL Acquisition Without Approval From FTC
2021-08-19
Antibody
ExeVir Bio’s COVID-19 Neutralizing Antibody Derived From Llamas Advances to Phase 1 Trials
2021-08-19
Innovation Organoids
Engineered Human Brain Organoids Develops Primitive Eye Like Structures
2021-08-19
Innovation Gene Therapy
Scientists Develop Drug Inducible Switch to Regulate Gene Therapy
2021-08-18
1 … 31 32 33 34 35 … 60
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top